Company: CRESW
Filing Date: 2025-10-24
Form Type: 20-F
Source: 0001654954-25-012195
Chunk: 387

Company: CRESUD INC
Filing Date: 2025-10-24
Form: 20-F
Item: Item 9
Chunk 387
---
 available for trading on NASDAQ and ByMA under the tickers CRESW and CRE3W, respectively. On November 8, 2024, we informed that the terms and conditions of the outstanding warrants for common shares of the Company have been modified as a result of the payment of a cash dividend to the shareholders on November 7, 2024, being the current Ratio of 1.4075 shares per option and a price of USD 0.4019 per share.

On September 25, 2025, we informed that our Board of Directors resolved to call an Ordinary and Extraordinary General Shareholders’ Meeting to be held on October 30, 2025 and as an item on the agenda, it was decided to consider the subscription of an addendum to the warrant agreement dated February 24, 2021, as amended on September 17, 2021 to incorporate the option of the warrant holders to exercise the warrants on a cashless basis. For more information, see “Item 4. Information on the Company —A. History and Development of the Company— Recent Developments— Cresud’s Recent Developments —General Ordinary and Extraordinary Shareholders’ Meeting”.

217

As of June 30, 2025, the capital stock of the Company was 614,074,273 common shares and the outstanding warrants were 73,294,802. On September 30, 2025, we informed that between September 17, 2025, and September 25, 2025, certain holders of warrants had exercised their right to acquire additional shares of the Company. As a result, 12,625,236 options were exercised, which resulted in 17,769,882 common shares of the Company being issued. After the exercise of these warrants, the number of shares and the capital stock of the Company increased from 614,074,273 to 631,844,155, and the number of outstanding warrants decreased from 73,294,802 to 60,669,566. For more information see “Recent Developments – Exercise of Warrants.”

As of that date of this Annual Report: (1) we had no other shares of any class or series issued and outstanding; and (2) there are no outstanding convertible notes to acquire our shares. Our common shares have one vote per share. All outstanding shares are validly issued, fully paid and non-assessable. As of June 30, 2025, there were approximately